{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:01:01Z","timestamp":1784764861517,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.maturitas.2026.109025","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:02:48Z","timestamp":1781136168000},"page":"109025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Obesity treatment for postmenopausal women: Established therapies and emerging approaches - a narrative review"],"prefix":"10.1016","volume":"211","author":[{"given":"Micha\u0142","family":"Kunicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Katulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Wolert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kunicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.maturitas.2026.109025_bb0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109025_bb0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0020","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ije\/dyz273","article-title":"Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic","volume":"49","author":"Wang","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.maturitas.2026.109025_bb0025","doi-asserted-by":"crossref","unstructured":"NCD Risk Factor Collaboration. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 16;403(10431) (2024) 1027\u20131050. doi:https:\/\/doi.org\/10.1016\/S0140-6736(23)02750-2.","DOI":"10.1016\/S0140-6736(23)02750-2"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/GME.0000000000000324","article-title":"Body mass index and age at natural menopause: a meta-analysis","volume":"22","author":"Tao","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109025_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.107966","article-title":"Menopausal hormone therapy: a review of metabolic and thermogenic effects","volume":"188","author":"Weidlinger","year":"2024","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.6118\/jmm.2016.22.1.14","article-title":"The association between body mass index and hot flash in midlife women: a meta-analysis","volume":"22","author":"Shobeiri","year":"2016","journal-title":"J. Menopausal Med."},{"key":"10.1016\/j.maturitas.2026.109025_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-023-02788-0","article-title":"The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis","volume":"24","author":"Gu","year":"2024","journal-title":"BMC Womens Health"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0050","first-page":"243","article-title":"Effect of low-dose or standard-dose conjugated equine estrogen combined with different progesterone on bone density in menopause syndrome women","volume":"53","author":"Zuo","year":"2018","journal-title":"Zhonghua Fu Chan Ke Za Zhi."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41366-023-01266-9","article-title":"Longitudinal patterns of abdominal visceral and subcutaneous adipose tissue, total body composition, and anthropometric measures in postmenopausal women: results from the Women\u2019s Health Initiative","volume":"47","author":"Banack","year":"2023","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.maturitas.2026.109025_bb0060","doi-asserted-by":"crossref","unstructured":"Lambrinoudaki I, Brincat M, Erel CT, Gambacciani M, Moen MH, Schenck-Gustafsson K, et al. EMAS position statement: managing obese postmenopausal women. Maturitas 66(3):323e6 (2010). doi:https:\/\/doi.org\/10.1016\/j.maturitas.2010.03.025.","DOI":"10.1016\/j.maturitas.2010.03.025"},{"key":"10.1016\/j.maturitas.2026.109025_bb0065","article-title":"Exercise and nutrition strategies for sarcopenia in older adults: evidence from a network meta-analysis based on EWGSOP and AWGS criteria","author":"Zhao","year":"2025","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.maturitas.2026.109025_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065425","article-title":"Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey","volume":"12","author":"Li","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.maturitas.2026.109025_bb0075","doi-asserted-by":"crossref","unstructured":"Greendale GA, Sternfeld B, Huang MH, Han W, Karvonen-Gutierrez C, Ruppert K, et al. Changes in body composition and weight during the menopause transition. JCI Insight 7;4(5):e124865 (2019). doi:https:\/\/doi.org\/10.1172\/jci.insight.124865.","DOI":"10.1172\/jci.insight.124865"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0080","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.109285","article-title":"Anthropometric indices and age at natural menopause: a 15-year follow-up population-based study","volume":"19","author":"Farahmand","year":"2021","journal-title":"Int. J. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.109025_bb0085","doi-asserted-by":"crossref","unstructured":"Karvonen-Gutierrez C, Kim C. Association of mid-life changes in body size, body composition and obesity status with the menopausal transition Vol. 4, Healthcare (Switzerland). MDPI. 4(3):42 (2016). doi:https:\/\/doi.org\/10.3390\/healthcare4030042.","DOI":"10.3390\/healthcare4030042"},{"key":"10.1016\/j.maturitas.2026.109025_bb0090","doi-asserted-by":"crossref","unstructured":"Greendale GA, Han W, Finkelstein JS, Burnett-Bowie SAM, Huang MH, Martin D, et al. Changes in regional fat distribution and anthropometric measures across the menopause transition. J. Clin. Endocrinol. Metab. 106(9):2520e34 (2021). doi:https:\/\/doi.org\/10.1210\/clinem\/dgab389.","DOI":"10.1210\/clinem\/dgab389"},{"key":"10.1016\/j.maturitas.2026.109025_bb0095","doi-asserted-by":"crossref","unstructured":"Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N, et al. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 30:14e27 (2022). doi:https:\/\/doi.org\/10.1002\/oby.23289.","DOI":"10.1002\/oby.23289"},{"key":"10.1016\/j.maturitas.2026.109025_bb0100","doi-asserted-by":"crossref","unstructured":"Reimer RA, Debert CT, House JL, et al. Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy. Physiol. Behav. 84(2) (2005) 303\u2013312. doi:https:\/\/doi.org\/10.1016\/j.physbeh.2004.12.011.","DOI":"10.1016\/j.physbeh.2004.12.011"},{"key":"10.1016\/j.maturitas.2026.109025_bb0105","doi-asserted-by":"crossref","unstructured":"Wing RR, Matthews KA, Kuller LH, et al. Weight gain at the time of menopause. Arch. Intern. Med. 151(1) (1991) 97\u2013102.","DOI":"10.1001\/archinte.1991.00400010111016"},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2012-1055","article-title":"The role of estrogens in control of energy balance and glucose homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2011.04.014","article-title":"The ovarian hormone estradiol plays a crucial role in the control of food intake in females","volume":"104","author":"Eckel","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.maturitas.2026.109025_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.108119","article-title":"A systematic review and meta-analysis investigating differences in chronic inflammation and adiposity before and after menopause","author":"Pernoud","year":"2024","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109025_bb0125","article-title":"Iodinedeficiency in patients with hypothyroidism: a pilot study","volume":"2022","author":"Veggel","year":"2022","journal-title":"J. Thyroid. Res."},{"key":"10.1016\/j.maturitas.2026.109025_bb0130","doi-asserted-by":"crossref","unstructured":"Gietka-Czernel M. The thyroid gland in postmenopausal women: physiology and diseases Prz. Menopauzalny 16(2) (2017) 33\u20137. doi.org\/https:\/\/doi.org\/10.5114\/pm.2017.68588.","DOI":"10.5114\/pm.2017.68588"},{"key":"10.1016\/j.maturitas.2026.109025_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0378-5122(81)90035-9","article-title":"Climacteric symptoms according to body weight in women of different socio-economic groups","volume":"3","author":"Campagnoli","year":"1981","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109025_bb0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.fertnstert.2013.05.005","article-title":"Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women\u2019s Health across the Nation","volume":"100","author":"Thurston","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2026.109025_bb0145","doi-asserted-by":"crossref","unstructured":"Gold EB, Crawford SL, Shelton JF, Tepper PG, Crandall CJ, Greendale GA, et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: The Study of Women's Health Across the Nation (SWAN). Menopause 24(1):9e26 (2017). doi:https:\/\/doi.org\/10.1097\/GME.0000000000000723.","DOI":"10.1097\/GME.0000000000000723"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-017-0487-7","article-title":"Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study","volume":"17","author":"Koo","year":"2017","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.maturitas.2026.109025_bb0155","doi-asserted-by":"crossref","unstructured":"Sievert LL, Whitcomb BW, Verjee MA, Gerber LM. Limited evidence of a threshold effect for increasing adiposity on risk of symptoms at midlife. Menopause 29(12):1381e 7 (2022). doi:https:\/\/doi.org\/10.1097\/GME.0000000000002074.","DOI":"10.1097\/GME.0000000000002074"},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/gme.0b013e31815879cf","article-title":"Abdominal adiposity and hot flashes among midlife women","volume":"15","author":"Thurston","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109025_bb0165","doi-asserted-by":"crossref","unstructured":"Salpeter SR, Walsh JME, Ormiston TM, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obesity Metab. 8:538\u201354 (2006). doi:https:\/\/doi.org\/10.1111\/j.1463-1326.2005.00545.x.","DOI":"10.1111\/j.1463-1326.2005.00545.x"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109025_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09513590601152177","article-title":"Effects of postmenopausal hormone replacement therapy on body fat composition","volume":"23","author":"Y\u00fcksel","year":"2007","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.maturitas.2026.109025_bb0175","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI2773","article-title":"The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women","volume":"102","author":"O\u2019sullivan","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.maturitas.2026.109025_bb0180","first-page":"170","article-title":"Metabolic effects of oestrogens: impact of the route of administration","volume":"64","author":"Ho","year":"2003","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.maturitas.2026.109025_bb0185","doi-asserted-by":"crossref","unstructured":"dos Reis CM, de Melo NR, Meirelles ES, et al. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas 46 (2003) 59\u201368. doi:https:\/\/doi.org\/10.1016\/s0378-5122(03)00159-2.","DOI":"10.1016\/S0378-5122(03)00159-2"},{"issue":"13","key":"10.1016\/j.maturitas.2026.109025_bb0190","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"ELITE Research Group. Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.109025_bb0195","doi-asserted-by":"crossref","unstructured":"C. Hemachandra, S. Taylor, R. M. Islam, E. Fooladi, and S. R. Davis, \u201cA systematic review and critical appraisal of menopause guidelines,\u201dBMJ Sex. Reprod. Health. 50, no. 2 (2024) 122\u2013138, doi.org\/https:\/\/doi.org\/10.1136\/bmjsrh-2023-202099.","DOI":"10.1136\/bmjsrh-2023-202099"},{"key":"10.1016\/j.maturitas.2026.109025_bb0200","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1038\/s41598-023-35826-w","article-title":"Oral micronized progesterone for perimenopausal night sweats and hot flushes: a phase III Canada-wide randomized placebo-controlled 4-month trial","volume":"13","author":"Prior","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109025_bb0205","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab011","article-title":"Hormone therapy in menopause: concepts, controversies, and approach to treatment","volume":"42","author":"Flores","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.maturitas.2026.109025_bb0210","doi-asserted-by":"crossref","unstructured":"dos Reis CM, de Melo NR, Meirelles ES, et al. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas 46 (2003) 59\u201368 doi:https:\/\/doi.org\/10.1016\/s0378-5122(03)00159-2.","DOI":"10.1016\/S0378-5122(03)00159-2"},{"key":"10.1016\/j.maturitas.2026.109025_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/cen.15211","article-title":"Update on menopause hormone therapy; current indications and unanswered questions","author":"Mukherjee","year":"2025","journal-title":"Clin. Endocrinol."},{"issue":"10","key":"10.1016\/j.maturitas.2026.109025_bb0220","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/oby.2001.81","article-title":"Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy","volume":"9","author":"S\u00f8rensen","year":"2001","journal-title":"Obes. Res."},{"key":"10.1016\/j.maturitas.2026.109025_bb0225","unstructured":"Polish Society for the Treatment of Obesity. Clinical practice guidelines for the management of patients with obesity. 2024; Med. Pr. 2024; p. 70\u201391."},{"key":"10.1016\/j.maturitas.2026.109025_bb0230","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.eprac.2025.07.017","article-title":"American Association of Clinical Endocrinology consensus statement: algorithm for the evaluation and treatment of adults with obesity\/adiposity-based chronic disease\u20142025 update","volume":"31","author":"Nadolsky","year":"2025","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0005-2760(88)90260-3","article-title":"Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin","volume":"962","author":"Borgstr\u00f6m","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.maturitas.2026.109025_bb0240","doi-asserted-by":"crossref","unstructured":"Sj\u00f6str\u00f6m, L., et al., Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 352(9123) (1998) 167\u201372. doi:https:\/\/doi.org\/10.1016\/s0140-6736(97)11509-4.","DOI":"10.1016\/S0140-6736(97)11509-4"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109025_bb0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/2230-8210.81938","article-title":"Evaluation of efficacy and safety of orlistat in obese patients","volume":"15","author":"Jain","year":"2011","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial","volume":"281","author":"Davidson","year":"1999","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.maturitas.2026.109025_bb0255","first-page":"472","article-title":"Impact of mass-reductive therapy with orlistat on serum 25-hydroxyvitamin D and parathyroid hormone concentrations in obese menopausal women","volume":"59","author":"Holecki","year":"2008","journal-title":"Endokrynol. Pol."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0260","first-page":"15","article-title":"Effects of short-term treatment with orlistat on the growth hormone\/insulin-like growth factor-I axis in obese postmenopausal women","volume":"34","author":"Somma","year":"2011","journal-title":"J. Endocrinol. Investig."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109025_bb0265","first-page":"255","article-title":"Naltrexone SR\/Bupropion SR (Contrave): a new approach to weight loss in obese adults","volume":"36","author":"Ornellas","year":"2011","journal-title":"Pt"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109025_bb0270","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Committee, A.G.A.C.G","year":"2022","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109025_bb0275","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.maturitas.2026.109025_bb0280","doi-asserted-by":"crossref","unstructured":"Greenway F.L., Fujioka K., Plodkowski R.A. i wsp.: Effect of naltrexone plus bupropionon weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 376 (2010) 595\u2013605. doi:https:\/\/doi.org\/10.1016\/S0140-6736(10)60888-4.","DOI":"10.1016\/S0140-6736(10)60888-4"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0285","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2003.05.036","article-title":"Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study","volume":"81","author":"Cucinelli","year":"2004","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.maturitas.2026.109025_bb0290","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109025_bb0295","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.maturitas.2026.109025_bb0300","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.maturitas.2026.109025_bb0310","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.109025_bb0315","article-title":"Antidiabetic agents and dementia risk in type 2 diabetes: a systematic review and network meta-analysis","author":"Kato","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.maturitas.2026.109025_bb0320","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083039","article-title":"Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis","author":"Nong","year":"2025","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.maturitas.2026.109025_bb0325","first-page":"1389","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"326","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0330","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/GME.0000000000002310","article-title":"Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use","volume":"31","author":"Hurtado","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109025_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0345","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.109025_bb0350","doi-asserted-by":"crossref","unstructured":"Tchang BG, et al. Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program. JP.Obesity (Silver Spring). 33(5) (2025) 851\u2013860. doi:https:\/\/doi.org\/10.1002\/oby.24254.","DOI":"10.1002\/oby.24254"},{"key":"10.1016\/j.maturitas.2026.109025_bb0360","doi-asserted-by":"crossref","unstructured":"Coskun T, Urva S, Roell WC, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metab. 34(9)1234.e9\u20131247.e9 (2022). doi:https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013.","DOI":"10.1016\/j.cmet.2022.07.013"},{"key":"10.1016\/j.maturitas.2026.109025_bb0365","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013hormone-receptor agonist retatrutide for obesity \u2014 a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/dom.70209","article-title":"Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials","volume":"28","author":"Giblin","year":"2026","journal-title":"Diabetes Obes. Metab."},{"issue":"10317","key":"10.1016\/j.maturitas.2026.109025_bb0375","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight or obesit:a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2026.109025_bb0380","doi-asserted-by":"crossref","unstructured":"Garvey WT, Bl\u00fcher M, Osorto Contreras CK, et al. Coadministered cagrilintide and semaglutide in adults with overweight or obesity. N. Engl. J. Med. 4;393(7) (2025) 635\u2013647 doi:https:\/\/doi.org\/10.1056\/NEJMoa2502081.","DOI":"10.1056\/NEJMoa2502081"},{"key":"10.1016\/j.maturitas.2026.109025_bb0385","doi-asserted-by":"crossref","unstructured":"Davies MJ, Bajaj HS, Broholm C, et al. Cagrilintide-semaglutide in adults with overweight or obesity and type 2 diabetes. N. Engl. J. Med. 4;393(7) (2025) 648\u2013659 doi:https:\/\/doi.org\/10.1056\/NEJMoa2502082.","DOI":"10.1056\/NEJMoa2502082"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109025_bb0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-21-0895","article-title":"Long-term body composition improvement in post-menopausal women following bariatric surgery: a cross-sectional and case-control study","volume":"186","author":"Santini","year":"2022","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.maturitas.2026.109025_bb0395","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamasurg.2025.3590","article-title":"Obesity treatment with bariatric surgery vs GLP-1 receptor agonists","volume":"160","author":"Barrett","year":"2025","journal-title":"JAMA Surg."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109025_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 ASMBS\/IFSO indications for metabolic and bariatric surgery","volume":"33","author":"Eisenberg","year":"2023","journal-title":"Obes. Surg."},{"issue":"12","key":"10.1016\/j.maturitas.2026.109025_bb0405","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","article-title":"Weight and metabolic outcomes 12 years after gastric bypass","volume":"377","author":"Adams","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.maturitas.2026.109025_bb0410","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.soard.2021.05.021","article-title":"Obstructive sleep apnea remission following bariatric surgery: a national registry cohort study","volume":"17","author":"Currie","year":"2021","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109025_bb0415","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/SLA.0000000000003331","article-title":"Bariatric surgery is associated with reduced risk of breast cancer in both premenopausal and postmenopausal women","volume":"272","author":"Feigelson","year":"2020","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109025_bb0420","article-title":"Procedure-specific early complications following bariatric surgery: a high-volume single-institution analysis","volume":"35","author":"Abi Mosleh","year":"2025","journal-title":"Surg. Laparosc. Endosc. Percutan. Tech."},{"issue":"11","key":"10.1016\/j.maturitas.2026.109025_bb0425","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s11695-013-1073-1","article-title":"Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study","volume":"23","author":"Froehling","year":"2013","journal-title":"Obes. Surg."},{"issue":"7","key":"10.1016\/j.maturitas.2026.109025_bb0430","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s11695-025-07933-2","article-title":"Chronic abdominal pain and gastrointestinal symptoms 12 years after primary Roux-en-Y gastric bypass: a cross-sectional controlled study","volume":"35","author":"Hyldmo \u00c5","year":"2025","journal-title":"Obes. Surg."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0435","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.soard.2025.12.004","article-title":"Marginal ulcer after gastric bypass surgery in France: a nationwide, population-based study","volume":"22","author":"Grellet","year":"2026","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.maturitas.2026.109025_bb0440","article-title":"Predictors of post-bariatric surgery hypoglycemia: a multicenter retrospective cohort study. Endocrinol","author":"Bahardoust","year":"2025","journal-title":"Diabetes Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109025_bb0445","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11695-025-08428-w","article-title":"Comprehensive long-term outcomes and durability of sleeve gastrectomy with up to 14 years of follow-up","volume":"36","author":"Abedalqader","year":"2026","journal-title":"Obes. Surg."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109025_bb0450","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11695-014-1177-2","article-title":"Outcomes of laparoscopic sleeve gastrectomy in patients older than 60 years","volume":"24","author":"Mizrahi","year":"2014","journal-title":"Obes. Surg."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109025_bb0455","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jbmr.3371","article-title":"Effects of gastric bypass surgery on bone mass and microarchitecture occur early and particularly impact postmenopausal women","volume":"33","author":"Schafer","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.maturitas.2026.109025_bb0460","doi-asserted-by":"crossref","first-page":"e2654","DOI":"10.1210\/clinem\/dgae830","article-title":"Skeletal effects of sleeve gastrectomy, by sex and menopausal status and compared to Roux-En-Y gastric bypass surgery","volume":"110","author":"Wu","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.109025_bb0465","doi-asserted-by":"crossref","unstructured":"Wal\u0119dziak, M. and A.M. R\u00f3\u017ca\u0144ska-Wal\u0119dziak, Bariatric surgery and menopause. Prz Menopauzalny. 21(4) (2022) 242\u2013245. doi:https:\/\/doi.org\/https:\/\/doi.org\/10.5114\/pm.2022.116885.","DOI":"10.5114\/pm.2022.116885"},{"issue":"10","key":"10.1016\/j.maturitas.2026.109025_bb0470","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s11695-013-0984-1","article-title":"Greater short-term weight loss in women 20-45 versus 55-65 years of age following bariatric surgery","volume":"23","author":"Ochner","year":"2013","journal-title":"Obes. Surg."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109025_bb0475","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s00464-019-06922-8","article-title":"Determining changes in bone metabolism after bariatric surgery in postmenopausal women","volume":"34","author":"Luhrs","year":"2020","journal-title":"Surg. Endosc."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109025_bb0480","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jbm4.10048","article-title":"Bone health after bariatric surgery","volume":"2","author":"Gagnon","year":"2018","journal-title":"JBMR Plus."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:02:21Z","timestamp":1784761341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":95,"alternative-id":["S0378512226002021"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109025","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity treatment for postmenopausal women: Established therapies and emerging approaches - a narrative review","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109025"}}